Press release
Key Influencer in the Analgesics Market 2025: Elevated Prevalence Of Chronic Diseases Fuels Growth In The Analgesics Market Driver
"How Are the key drivers contributing to the expansion of the analgesics market?The growing frequency of chronic health conditions fuels the expansion of the analgesics market. Analgesics, colloquially known as painkillers, are employed in combating extreme or long-lasting pain resulting from a variety of health disorders. For instance, a report from the World Health Organization (WHO) in September 2022 pointed out that chronic diseases, also dubbed noncommunicable diseases (NCDs), materialize over an extended duration due to a mixture of genetic factors, physiological conditions, environment, and behaviors. As per the report, NCDs are responsible for 41 million deaths annually, which equates to 74% of all global deaths. Every year, 17 million individuals succumb to an NCD before reaching 70 years of age. Such premature deaths comprise 86% of fatalities in low- and middle-income countries, where 77% of deaths due to NCDs occur. Consequently, the escalating occurrence of chronic diseases propels the growth of the analgesics market.
Get Your Analgesics Market Report Here:
https://www.thebusinessresearchcompany.com/report/analgesics-global-market-report
What growth opportunities are expected to drive the analgesics market's CAGR through 2034?
The market size of analgesics has seen a steady increase in the recent past. It's slated to expand from $109.97 billion in 2024 to $113.96 billion in 2025, registering a compound annual growth rate (CAGR) of 3.6%. Factors such as the influence of alternative therapies, results of safety and efficacy studies, prevalence of pain, marketing, promotional activities, and economic influences can be credited for the growth observed in the historic period.
The market size of analgesics is projected to witness consistent expansion in the ensuing years, reaching $129.46 billion by 2029 with an annual growth rate of 3.2%. Factors contributing to the growth during the forecast period include alternatives for pain management, market rivalry, consumer health knowledge, demographic changes, and increasing chronic diseases. Key trends for the same period involve personalized medicine, non-opioid alternatives, the use of CB*D and cannabinoids, focused pain management, and affordable, accessible options.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2438&type=smp
What trends are poised to drive the future success of the analgesics market?
The analgesics market is witnessing an increasing trend of companies focusing on investments to drive their growth. Prominent manufacturers of analgesic drugs are strategically investing in clinical-stage firms to secure a competitive edge and bolster their stance in the market. These investments allow the businesses to broaden their geographical presence and acquire specialized skills in researching and developing novel products. For instance, in January 2022, Concentric Analgesics, Inc., a US based clinical-stage biopharmaceutical firm, finished a $20 million convertible note financing from a blend of fresh and existing investors. The funding will be channeled towards launching registration-empowering Phase 3 studies for Vocacapsaicin, the firm's Phase 3-ready principal product candidate. Additionally, the financing will also support the continued Phase 3 development endeavors for Vocacapsaicin, Concentric Analgesics' leading therapeutic candidate for treating post-operative pain. The successful closing of the financing deal is a significant milestone for Concentric Analgesics as it facilitates the company to move forward with Vocacapsaicin's Phase 3 development, and marks a crucial initial step in completely financing the program until NDA submission.
Which growth-oriented segments of the analgesics market are leading the industry's development?
The analgesics market covered in this report is segmented -
1) By Type: Non-opioids, Opioids
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores
3) By Application: Internal Analgesics, External Analgesics
Subsegments:
1) By Non-Opioids: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Acetaminophen (Paracetamol), Salicylates
2) By Opioids: Natural Opioids, Semi-Synthetic Opioids, Synthetic Opioids
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2438
What regions are leading the charge in the analgesics market?
North America was the largest region in the analgesics market in 2024. Middle East is expected to be the fastest-growing region in the global analgesics market during the forecast period. The regions covered in the analgesics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What companies are at the forefront of innovation in the analgesics market?
Major companies operating in the analgesics market include Pfizer Inc., Johnson & Johnson Services Inc., Medley Pharmaceuticals Limited, AbbVie Inc., Bayer HealthCare Pharmaceuticals LLC, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Co., AstraZeneca Plc., Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical company Limited, Eli Lilly and Company, Reckitt Benckiser Group plc, Viatris Inc., Teva Pharmaceuticals Industries Ltd., Sun Pharmaceutical Industries Limited, Purdue Pharma L.P, Cipla Limited, Allergan Inc., Endo International plc, Amneal Pharmaceuticals LLC, Mallinckrodt Pharmaceuticals Ltd., Chattem Inc., Hisamitsu Pharmaceutical Co.Inc., GW Pharmaceuticals, Verve Health Care Ltd., Alder BioPharmaceuticals Inc., Achelios Therapeutics Inc., WEX Pharmaceuticals Inc., Zynerba Pharmaceuticals, McNeil Consumer & Specialty Medical Products, Innovative Med Concepts LLC
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=2438&type=smp
What Is Covered In The Analgesics Global Market Report?
• Market Size Forecast: Examine the analgesics market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the analgesics market for a structured understanding.
• Key Players Overview: Analyze major players in the analgesics market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the analgesics market.
• Segment Contributions: Evaluate how different segments drive overall growth in the analgesics market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the analgesics market.
• Industry Challenges: Identify potential risks and obstacles affecting the analgesics market.
• Competitive Landscape: Review strategic developments in the analgesics market, including expansions, agreements, and new product launches.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ"
Learn More About The Business Research Company
The Business Research Company provides in-depth research and insights through a vast collection of 15,000+ reports spanning 27 industries and over 60 geographies. Backed by 1,500,000 datasets, extensive secondary research, and expert insights from industry leaders, we equip you with the knowledge needed to stay ahead in the market.
Our flagship offering, the Global Market Model, is a leading market intelligence platform that delivers comprehensive and up-to-date forecasts to support strategic decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Key Influencer in the Analgesics Market 2025: Elevated Prevalence Of Chronic Diseases Fuels Growth In The Analgesics Market Driver here
News-ID: 3903091 • Views: …
More Releases from The Business research company

Unlocking Opportunities in the Tyrosine Kinase Inhibitors Market: 2025-2034 Fore …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Tyrosine Kinase Inhibitors Industry Market Size Be by 2025?
The market for tyrosine kinase inhibitors has seen robust growth in recent times. The market is predicted to expand from $58.03 billion in 2024 to $62.66 billion in 2025, marking a compound annual growth rate (CAGR) of…

Sustained Release Excipients Market Advances With Product Innovation Industry Tr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Sustained Release Excipients Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the market size of sustained release excipients has seen significant growth. It's projected to increase from $1.4 billion in 2024 to $1.51 billion in 2025, exhibiting a Compound Annual Growth Rate…

Surge In Cancer Cases Fuels Expansion Of The RNA-Targeting Small Molecule Therap …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the RNA Targeting Small Molecules Therapeutics Market Size By 2025?
In recent years, the market size of RNA targeting small molecules therapeutics has witnessed substantial growth. The market, which is estimated to be worth $6.1 billion in 2024, is projected to increase to $7.83 billion in…

Surge In Autoimmune Diseases Fuels Remicade Biosimilar Market Growth Emerges as …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Remicade Biosimilar Market Through 2025?
In recent times, we've seen significant expansion in the remicade biosimilar market. Projected growth from 2024's $3.95 billion to $4.89 billion in 2025 indicates a compound annual growth rate (CAGR) of 23.8%. This rise during the historic…
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…